HORIZON PHARMA PLC - SHS (HZNP)

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / SHS
Total 13F shares
147,592,050
Share change
+5,275,733
Total reported value
$2,444,035,109
Put/Call ratio
45%
Price per share
$16.56
Number of holders
201
Value change
+$99,063,249
Number of buys
103
Number of sells
90

Institutional Holders of HORIZON PHARMA PLC - SHS (HZNP) as of Q2 2018

As of 30 Jun 2018, HORIZON PHARMA PLC - SHS (HZNP) was held by 201 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 147,592,050 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., SCOPIA CAPITAL MANAGEMENT LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, PAULSON & CO. INC., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), venBio Select Advisor LLC, DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, and RENAISSANCE TECHNOLOGIES LLC. This page lists 201 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.